Conclusion
There is an independent graded negative association between levels of
eGFR levels at admission and mortality in patients with intracerebral
hemorrhage. Patients with intracerebral hemorrhage and eGFR levels
<15 ml/min/1.73 m2 have a near 4-fold
increased hazard of deaths compared to those with intracerebral
hemorrhage and eGFR levels ≥ 90 mL/min/1.73m2. The
eGFR level could be used as an early biomarker to identify high
mortality risks for patients with intracerebral hemorrhage. Patients
with intracerebral hemorrhage and a low eGFR deserve more clinical
attention and closer follow-up monitoring.